The active ingredient in Latisse is bimatoprost, a medication that was originally developed for the treatment of glaucoma and ...

Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...